[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335267-105":59,"doc-detail-335267-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-use-of-organoids-in-creating-immune-microenvironments-and-treating-gynecological-tumors","The use of organoids in creating immune microenvironments and treating gynecological tumors","","Cancer stem cell-derived three-dimensional tumor organoids enable in vitro modeling that reflects structural, phenotypic, and genetic features of patient tumors, supporting drug testing, genome editing, and transplantation toward precision medicine. Yet organoids often inadequately model immune and stromal components of the tumor microenvironment, while modern immunotherapy increases the need to simulate patient-specific tumor–immune interactions. This review evaluates recent tumor organoid co-culture advances with immune cell models and summarizes their relevance, therapeutic roles, and challenges for gynecological tumors.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-use-of-organoids-in-creating-immune-microenvironments-and-treating-gynecological-tumors/335267/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-use-of-organoids-in-creating-immune-microenvironments-and-treating-gynecological-tumors/335267.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are tumor organoids important for personalized cancer treatment?","Question",{"text":113,"@type":114},"Tumor organoids are patient-derived and three-dimensional, so they replicate key structural, phenotypic, and genetic characteristics of tumors, supporting precision medicine and personalized investigations.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What limitation restricts organoids in modeling tumor immune microenvironments?",{"text":118,"@type":114},"Their inadequate capacity to effectively model immune cells and stromal components within the tumor microenvironment limits their ability to capture tumor–immune interactions.",{"name":120,"@type":111,"acceptedAnswer":121},"How do co-culture techniques expand the value of organoids?",{"text":122,"@type":114},"By integrating tumor organoids with immune cells and tumor microenvironment constituents, co-culture approaches improve the ability to study patient-specific tumor–immune interactions and guide clinical research for gynecological tumors.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},335267,1790154687,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Zhou et al. Journal of Translational Medicine (2024) 22:856  \n[https://doi.org/10.1186/s12967-024-05649-y](https://doi.org/10.1186/s12967-024-05649-y)  \nJournal of Translational Medicine  \nREVIEW Open Access  \nThe use of organoids in creating immune microenvironments and treating gynecological tumors  \nLing-Feng Zhou 1, Hui-Yan Liao 1, Yang Han 1 and Yang Zhao 1*  \nAbstract  \nOwing to patient-derived tumor tissues and cells, significant advances have been made in personalized cancer treatment and precision medicine, with cancer stem cell-derived three-dimensional tumor organoids serving as crucial in vitro models that accurately replicate the structural, phenotypic, and genetic characteristics of tumors. However, despite their extensive use in drug testing, genome editing, and transplantation for facilitating personalized treatment approaches in clinical practice, the inadequate capacity of these organoids to effectively model immune cell s and stromal components within the tumor microenvironment limits their potential. Additionally, effective clinical immunotherapy has led the tumor immune microenvironment to garner considerable attention, increasing the demand for simulating patient-specific tumor–immune interactions. Consequently, coculture techniques integrating tumor organoids with immune cells and tumor microenvironment constituents have been developed to expand the possibilities for personalized drug response investigations, with recent advancements enhancing the understanding of the strengths, limitations, and applicability of the co-culture approach. Herein, the recent advancements in the field of tumor organoids have been comprehensively reviewed, specifically highlighting the tumor organoid co-culture-related developments with various immune cell models and their implications for clinical research. Furthermore, this review delineates the current state of research and application of organoid models regarding the therapeutic approaches and related challenges for gynecological tumors. This study may provide a theoretical basis for further research on the use of patient-derived organoids in tumor immunity, drug development, and precision medicine.  \nKeywords Organoid, Immune cells, Cancer, Gynecological tumors, Co-cultivation model  \n*Correspondence:  \nYang Zhao  \n[yida.zhaoyang@163.com](yida.zhaoyang@163.com)  \n1Department of Obstetrics and Gynecology, Department of Gynecologic Oncology Research Office, Guangzhou Key Laboratory of Targeted Therapy for Gynecologic Oncology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, No.63 Duobao Road, Liwan District, Guangzhou City, Guangdong Province, P. R. China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://](http://)[ ](http://)[creativecommons.org/l](creativecommons.org/l)icenses/by-","cbCaigjJdIc8izP1","https://ap.wps.com/l/cbCaigjJdIc8izP1","pdf",1367652,13,"English","# Abstract\n# Introduction\n## Limitations of current preclinical models\n## Advantages of patient-derived organoids","[{\"question\":\"Why are tumor organoids important for personalized cancer treatment?\",\"answer\":\"Tumor organoids are patient-derived and three-dimensional, so they replicate key structural, phenotypic, and genetic characteristics of tumors, supporting precision medicine and personalized investigations.\"},{\"question\":\"What limitation restricts organoids in modeling tumor immune microenvironments?\",\"answer\":\"Their inadequate capacity to effectively model immune cells and stromal components within the tumor microenvironment limits their ability to capture tumor–immune interactions.\"},{\"question\":\"How do co-culture techniques expand the value of organoids?\",\"answer\":\"By integrating tumor organoids with immune cells and tumor microenvironment constituents, co-culture approaches improve the ability to study patient-specific tumor–immune interactions and guide clinical research for gynecological tumors.\"}]","The use of organoids in creating immune microenvironments and treating gynecological tumors | PDF",1790010344,33]